| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.069 | 0.6 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.028 | 0.6 |